Evidence map›Paper›PMID 28470843›Full record

ArticleJournal of cellular and molecular medicine2017

Combination of biochemical and mechanical cues for tendon tissue engineering.

Stefano Testa, Marco Costantini, Ersilia Fornetti, Sergio Bernardini, Marcella Trombetta, Dror Seliktar, Stefano Cannata, Alberto Rainer, Cesare Gargioli

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Three-Dimensional Cell Culture System for Tendon Tissue Engineering.Tissue engineering and regenerative medicine · 2023
    Review
  9. Article
  10. Article
  11. PersonalizedFrontiers in bioengineering and biotechnology · 2022
    Article
  12. Advanced Robotics to Address the Translational Gap in Tendon Engineering.Cyborg and bionic systems (Washington, D.C.) · 2022
    Review
  13. Article
  14. Review
  15. In Vitro Innovation of Tendon Tissue Engineering Strategies.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stefano TestaDepartment of Biology, Tor Vergata Rome University, Rome, Italy.
Marco CostantiniDepartment of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
Ersilia FornettiDepartment of Biology, Tor Vergata Rome University, Rome, Italy.
Sergio BernardiniDepartment of Biology, Tor Vergata Rome University, Rome, Italy.
Marcella TrombettaDepartment of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
Dror SeliktarDepartment of Biomedical Engineering, Techion Institute, Haifa, Israel.
Stefano CannataDepartment of Biology, Tor Vergata Rome University, Rome, Italy.
Alberto RainerDepartment of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
Cesare GargioliDepartment of Biology, Tor Vergata Rome University, Rome, Italy.ORCID http://orcid.org/0000-0003-1742-3969

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tendinopathies negatively affect the life quality of millions of people in occupational and athletic settings, as well as the general population. Tendon healing is a slow process, often with insufficient results to restore complete endurance and functionality of the tissue. Tissue engineering, using tendon progenitors, artificial matrices and bioreactors for mechanical stimulation, could be an important approach for treating rips, fraying and tissue rupture. In our work, C3H10T1/2 murine fibroblast cell line was exposed to a combination of stimuli: a biochemical stimulus provided by Transforming Growth Factor Beta (TGF-β) and Ascorbic Acid (AA); a three-dimensional environment represented by PEGylated-Fibrinogen (PEG-Fibrinogen) biomimetic matrix; and a mechanical induction exploiting a custom bioreactor applying uniaxial stretching. In vitro analyses by immunofluorescence and mechanical testing revealed that the proposed combined approach favours the organization of a three-dimensional tissue-like structure promoting a remarkable arrangement of the cells and the neo-extracellular matrix, reflecting into enhanced mechanical strength. The proposed method represents a novel approach for tendon tissue engineering, demonstrating how the combined effect of biochemical and mechanical stimuli ameliorates biological and mechanical properties of the artificial tissue compared to those obtained with single inducement.

Indexed as

AnimalsAscorbic AcidBiomimetic MaterialsBioreactorsCell Culture TechniquesCell LineExtracellular MatrixFibrinogenFibroblastsMechanotransduction, CellularMicePolyethylene GlycolsStress, MechanicalTendonsTissue EngineeringTissue ScaffoldsAscorbic AcidFibrinogenPolyethylene GlycolsTransforming Growth Factor betaartificial tendonbiomaterialbioreactormechanical stimulationtissue engineering

Identifiers

PMID28470843
PMCPMC5661263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.